Jackson S P
Wellcome/Cancer Research Campaign Institute, Cambridge University, UK.
Curr Biol. 1995 Nov 1;5(11):1210-2. doi: 10.1016/s0960-9822(95)00238-7.
ATM, the gene product mutated in the cancer susceptibility syndrome ataxia-telangiectasia, is related to proteins involved in DNA repair and cell-cycle control, perhaps explaining how ATM prevents carcinogenesis.
ATM是在癌症易感性综合征共济失调毛细血管扩张症中发生突变的基因产物,它与参与DNA修复和细胞周期控制的蛋白质有关,这或许可以解释ATM是如何预防癌症发生的。